Vincenza Conteduca Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Biography Publications Institution JoVE Articles Vincenza Conteduca has not added a biography. If you are Vincenza Conteduca and would like to personalize this page please email our Author Liaison for assistance. Publications Circulating Androgen Receptor Combined with 18F-fluorocholine PET/CT Metabolic Activity and Outcome to Androgen Receptor Signalling-directed Therapies in Castration-resistant Prostate Cancer Scientific Reports. Nov, 2017 | Pubmed ID: 29138500 Cell-free DNA As a Diagnostic Marker for Cancer: Current Insights OncoTargets and Therapy. 2016 | Pubmed ID: 27822059 Systemic Immune-inflammation Index Predicts the Clinical Outcome in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib Oncotarget. 08, 2016 | Pubmed ID: 27409344 Circulating AR Copy Number and Outcome to Enzalutamide in Docetaxel-treated Metastatic Castration-resistant Prostate Cancer Oncotarget. Jun, 2016 | Pubmed ID: 27191887 Early Outcome Prediction on 18F-fluorocholine PET/CT in Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Oncotarget. Dec, 2014 | Pubmed ID: 25504434 Plasmaprøver kopiere nummer Detection bruke sanntid PCR Samanta Salvi1, Vincenza Conteduca1, Filippo Martignano1, Giorgia Gurioli1, Daniele Calistri1, Valentina Casadio1 1Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 56502 Cancer Research
Plasmaprøver kopiere nummer Detection bruke sanntid PCR Samanta Salvi1, Vincenza Conteduca1, Filippo Martignano1, Giorgia Gurioli1, Daniele Calistri1, Valentina Casadio1 1Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 56502 Cancer Research